Scale-up of lentiviral vectors for gene therapy: advances and challenges
Files
(Published version)
Date
2017
Authors
McCarron, A.
Donnelley, M.
Parsons, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Cell and Gene Therapy Insights, 2017; 3(9):719-729
Statement of Responsibility
Alexandra McCarron, Martin Donnelley & David Parsons
Conference Name
Abstract
Growing interest in the use of lentiviral (LV) vectors for gene therapy applications has resulted in demand for production processes that are amenable to large scale. However, up-scaling LV manufacturing poses a number of challenges for process developers and regulatory bodies, which need to be overcome in order to cost effectively generate a gene therapy product in large quantities. Recently there has been progress in developing workflows capable of producing and processing LV vector at sufficient levels for human gene therapy applications. Accordingly, this article will cover the current state of LV upstream and downstream processing, ongoing challenges of up-scaling manufacturing, recent advances and improvements, and future perspectives.
School/Discipline
Dissertation Note
Provenance
Description
Published: Nov 16 2017
Access Status
Rights
This work is licensed under a Creative Commons Attribution – NonCommercial – NoDerivatives 4.0 International License